Analysts think ARTL stock price could increase by 278%
Aug 01, 2024, 6:25 AM
-5.93%
What does ARTL do
Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Solana Beach, California, focusing on developing therapeutics targeting lipid-signaling pathways, including the endocannabinoid system. The company, which went public in 2015, is advancing treatments such as ART27.13 for cancer-associated anorexia and ART26.12 for potential use in cancer, pain, inflammation, and anxiety-related disorders.
5 analysts think ARTL stock price will increase by 277.78%. The current median analyst target is $5.10 compared to a current stock price of $1.35. The lowest analysts target is $5.05 and the highest analyst target is $42.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
